ContractIndenture • November 27th, 2024 • TC BioPharm (Holdings) PLC • Biological products, (no disgnostic substances) • New York
Contract Type FiledNovember 27th, 2024 Company Industry JurisdictionINDENTURE, dated as of [ ], by and between TC Biopharm (Holdings) plc, a public limited company incorporated in Scotland pursuant to the Companies Act 2006 (the “Company”), and [ ], as trustee (the “Trustee”):
Marker Therapeutics, Inc., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [·], 20__ Debt SecuritiesIndenture • November 27th, 2024 • Marker Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledNovember 27th, 2024 Company Industry JurisdictionIndenture, dated as of [·], 20__, among Marker Therapeutics, Inc., a Delaware corporation (the “Company”), and [Trustee], as trustee (the “Trustee”):
ContractIndenture • November 27th, 2024 • TC BioPharm (Holdings) PLC • Biological products, (no disgnostic substances) • New York
Contract Type FiledNovember 27th, 2024 Company Industry JurisdictionINDENTURE, dated as of [ ], by and between TC Biopharm (Holdings) plc, a public limited company incorporated in Scotland pursuant to the Companies Act 2006 (the “Company”), and [ ], as trustee (the “Trustee”):